Chronic fatigue: changes in intestinal bacteria could explain your symptoms
Augusts 28, 2023
Information day at the CIBA to present the new proteomic analysis and Maldi Imaging services
Augusts 31, 2023
The Zaragoza ophthalmological technology company DIVE MEDICAL has obtained a capital injection of 1,15 million euros of CDTI, the Center for Technological Development and Innovation of Spain. A financial boost that will allow the startup to invest in R&D and that also comes as a result of recognition Seal of Excellence granted by the Horizon 2020 program of the European Union.
DIVE Medical has developed the first device that allows detect visual abnormalities in children as young as six months old. The child simply has to follow the images that appear on a screen, and in a matter of minutes, objective and reliable metrics can be obtained to facilitate screening, early diagnosis and monitoring of visual problems.
According to the startup itself, every minute a child loses the ability to see, a figure that they believe could be reduced if it were not for the lack of tools that allow visual disabilities to be detected in time in childhood. This worrying reality is further aggravated when considering the potential negative impact on children's general, social and cognitive development.
The pediatric ophthalmologist Victoria Pueyo, co-founder of DIVE Medical, highlights that “today it is a challenge to explore the vision of children under 4-5 years old or with neurocognitive problems. “We have developed a tool that allows us to detect visual alterations in a quick and comfortable way for the patient, her family and the healthcare professional.”
Social integration, endowment and recognitions
DIVE Medical's technology, which is based on the combination of eye tracking (eye tracking) and artificial intelligence, has the potential to be used to support the diagnosis and monitoring of other diseases such as autism, Parkinson's and Alzheimer's.
In relation to visual screening, the DIVE device can integrate into primary care centers and population screening programs to detect in a cost-effective way those patients who need to be referred to a specialist. This proposal was presented to the European Commission, receiving the Seal of Excellence, which allowed it to obtain subsequent financing of €1,15M from the Center for Industrial Technological Development (CDTI).
With this funding, DIVE Medical will advance the clinical validation of your visual screening technology, carrying out a Health Technology Assessment in several countries to demonstrate its effectiveness.
Additionally, DIVE Medical is currently accepting convertible loans as part of its strategy to close a Series A investment round next year. With this financial backing, the company aims to further expand its impact in the field of visual health and continue to innovate for the benefit of patients.
Thanks to its trajectory aimed at solving a relevant challenge for society, DIVE Medical has recently been awarded a Santander X Global Award – The AI Revolution, in the startup category. This competitive award has allowed DIVE to obtain financial aid and integrate into the SantanderX100 entrepreneurship ecosystem.
The Zaragoza startup that detects if your baby does not see well
DIVE arose from the difficulties ophthalmologists and pediatricians experience daily when examining the visual function of preverbal and nonverbal patients. Pediatric ophthalmologists and optometrists from the Miguel Servet Hospital, through the IIS Aragón, and engineers from the University of Zaragoza are working together to develop a device that enables rapid and accurate screening of visual function in young children. After five years of research, it was founded DIVE-Medical SL. to bring the benefits of this device to all ophthalmologists, pediatricians and optometrists.
Every day 11.000 children are born in the world with vision problems. However, their diagnosis is made, hopefully, from the age of three, which means that the consequences of their pathologies can worsen over time. To alleviate the defenselessness of the weakest, a startup Zaragoza, Dive Medical, has designed a prototype that takes advantage of the power of artificial intelligence (AI) for early diagnosis. And his invention not only arouses interest in the medical community, but has also caught the attention of Richard Yu himself, CEO of the technology giant Huawei, who wants to support its development.
